Effects of RAB1A on the proliferation, invasion, and metastasis of tongue squamous cell carcinoma cells

doi:10.7518/hxkq.2020.03.003

Abstract

Abstract:

Objective This study aimed to investigate the molecular mechanism of RAB1A in the proliferation, invasion, and metastasis of human tongue squamous cell carcinoma. Methods Western blot was used to detect the expression of RAB1A protein in human normal tongue epithelial cells (Hacat) and tongue squamous cell carcinoma Tca8113. The changes in RAB1A after plasmid transfection were also studied. The Tca8113 cells were named SiRAB1A/Tca8113 after RAB1A plasmid transfection. The expression of the epithelial-mesenchymal transition (EMT)-related markers of SiRAB1A/Tca8113 cells was also detected. CCK-8 assay was used to detect the proliferation of SiRAB1A/Tca8113 cells. Transwell and wound healing assays were used to detect the invasive and metastatic abilities of SiRAB1A/Tca8113 cells, respectively. Results Western blot results showed that the expression of RAB1A in tongue squamous cell carcinoma cells was significantly higher than that in Hacat. RAB1A decreased significantly after SiRAB1A plasmid transfection. CCK-8 proliferation assay showed that the proliferation of SiRAB1A/Tca8113 cells also decreased significantly. Transwell and wound healing assays demonstrated that the invasive and metastatic abilities of SiRAB1A/Tca8113 cells decreased significantly, respectively. In addition, Western blot results demonstrated that RAB1A deletion significantly increased the expression of E-cadherin and inhibited the expression of Vimentin. Conclusion RAB1A could promote the proliferation, invasion, and metastasis of tongue squamous cell carcinoma cells.

Key words: tongue squamous cell carcinoma, RAB1A, proliferation, invasion, metastasis, epithelial-mesenchymal transition

CLC Number:

R739.86

Sun Xuehui, Fan Xin, Hu Kaili, Hu Wenting. Effects of RAB1A on the proliferation, invasion, and metastasis of tongue squamous cell carcinoma cells[J]. West China Journal of Stomatology, 2020, 38(3): 245-249.

Figures/Tables 5

References 21

[1]	Torre LA, Bray F, Siegel RL , et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2):87-108. doi: 10.3322/caac.21262 URL
[2]	Tota JE, Anderson WF, Coffey C , et al. Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012[J]. Oral Oncol, 2017,67:146-152. doi: 10.1016/j.oraloncology.2017.02.019 URL
[3]	Siegel RL, Miller KD, Jemal A . Cancer statistics, 2019[J]. CA Cancer J Clin, 2019,69(1):7-34.
[4]	Li R, Koch WM, Fakhry C , et al. Distinct epidemiologic characteristics of oral tongue cancer patients[J]. Otolaryngol Head Neck Surg, 2013,148(5):792-796.
[5]	Jansen L, Buttmann-Schweiger N, Listl S , et al. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site[J]. Oral Oncol, 2018,76:8-15.
[6]	Li Y, Wang HY, Zheng XF . Rab1 GTPases as oncogene[J]. Aging, 2015,7(11):897-898. doi: 10.18632/aging.v7i11 URL
[7]	Thomas JD, Zhang YJ, Wei YH , et al. Rab1A is an mTORC1 activator and a colorectal oncogene[J]. Cancer cell, 2016,30(1):181-182. doi: 10.1016/j.ccell.2016.06.014 URL
[8]	Xu BH, Li XX, Yang Y , et al. Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A[J]. Oncotarget, 2015,6(25):20813-20828. doi: 10.18632/oncotarget.v6i25 URL
[9]	Bao ZS, Li MY, Wang JY , et al. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling[J]. CNS Neurosci Ther, 2014,20(2):112-118. doi: 10.1111/cns.12171 URL
[10]	Shimada K, Uzawa K, Kato M , et al. Aberrant expression of RAB1A in human tongue cancer[J]. Br J Cancer, 2005,92(10):1915-1921.
[11]	Yin C, Mou Q, Pan X , et al. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25[J]. Thorac Cancer, 2018,9(4):472-479. doi: 10.1111/tca.2018.9.issue-4 URL
[12]	Yin C, Zhang G, Sun R , et al. miR-185-5p inhibits F-actin polymerization and reverses epithelial mesenchymal transition of human breast cancer cells by modulating RAGE[J]. Mol Med Rep, 2018,18(3):2621-2630.
[13]	Charng WL, Yamamoto S, Jaiswal M , et al. Drosophila Tempura, a novel protein prenyltransferase αsubunit, regulates notch signaling via Rab1 and Rab11[J]. PLoS Biol, 2014,12(1):e1001777. doi: 10.1371/journal.pbio.1001777 URL
[14]	Bucci C, Alifano P . The role of rab proteins in neuronal cells and in the trafficking of neurotrophin receptors[J]. Membranes, 2014,4(4):642-677. doi: 10.3390/membranes4040642 URL
[15]	Quan Y, Song Q, Wang J , et al. MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1A[J]. Tumor Biol, 2017,39(4):1-10.
[16]	Zhang CZ, Cao Y, Fu J , et al. miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33[J]. Mol Oncol, 2016,10(10):1532-1541.
[17]	Xu H, Qian M, Zhao B , et al. Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells[J]. Oncol Rep, 2017,37(3):1619-1626.
[18]	Xie S, Lu Z, Lin Y , et al. Upregulation of PTEN suppresses invasion in Tca8113 tongue cancer cells through repression of epithelial-mesenchymal transition (EMT)[J]. Tumor Biol, 2016,37(5):6681-6689.
[19]	Huang W, Cui X, Chen J , et al. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition[J]. Oncotarget, 2016,7(38):62520-62532. doi: 10.18632/oncotarget.v7i38 URL
[20]	Fang Z, Zhang S, Wang Y , et al. Long non-coding RNA MALAT-1 modulates metastatic potential of tongue squamous cell carcinomas partially through the regulation of small proline rich proteins[J]. BMC cancer, 2016,16(9):706.
[21]	Liang J, Liang L, Ouyang K , et al. MALAT1 induces tongue cancer cells’ EMT and inhibits apoptosis through Wnt/β-catenin signaling pathway[J]. J Oral Pathol Med, 2017,46(2):98-105. doi: 10.1111/jop.2017.46.issue-2 URL